William Lis, Director at Jasper Therapeutics, Inc. (JSPR), sold 74,229 shares at $2.08 ($153K) on 2022-06-27, disclosed to the SEC on 2022-06-28.
Open-market sale of $153k JSPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.02 | 24,743 | $50K | 32.7% |
| 2 | $2.08 | 24,743 | $51K | 33.7% |
| 3 | $2.08 | 24,743 | $51K | 33.7% |
| Total | $2.06 avg | 74,229 | $153K | 100% |
| Filing → |
| ZLAB | SELL | 2025-06-23 | $985K | — | Filing → |
| ZLAB | SELL | 2025-03-04 | $989K | — | Filing → |
| ZLAB | SELL | 2024-07-03 | $358K | — | Filing → |